Level Chart

Basic Info

Becton Dickinson and Co (BDX) - Pharmaceutical Systems Revenue is at a current level of 431.00M, down from 659.00M last quarter and up from 409.00M one year ago. This is a change of -34.60% from last quarter and 5.38% from one year ago.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 431.00M
Latest Period Dec 2023
Last Updated Apr 30 2024, 08:41 EDT
Next Release Jul 31 2024, 08:30 EDT (E)
Average Growth Rate 20.95%
Value from Last Quarter 659.00M
Change from Last Quarter -34.60%
Value from 1 Year Ago 409.00M
Change from 1 Year Ago 5.38%
Frequency Quarterly
Unit USD
Adjustment N/A

Historical Data

View and export this data back to 2019. Upgrade now.
Date Value
December 31, 2023 431.00M
September 30, 2023 659.00M
June 30, 2023 594.00M
March 31, 2023 567.00M
December 31, 2022 409.00M
September 30, 2022 581.00M
June 30, 2022 523.00M
March 31, 2022 501.00M
December 31, 2021 397.00M
Date Value
September 30, 2021 552.00M
June 30, 2021 476.00M
March 31, 2021 462.00M
December 31, 2020 339.00M
September 30, 2020 485.00M
June 30, 2020 403.00M
March 31, 2020 400.00M
December 31, 2019 299.00M

Basic Info

Becton Dickinson and Co (BDX) - Pharmaceutical Systems Revenue is at a current level of 431.00M, down from 659.00M last quarter and up from 409.00M one year ago. This is a change of -34.60% from last quarter and 5.38% from one year ago.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 431.00M
Latest Period Dec 2023
Last Updated Apr 30 2024, 08:41 EDT
Next Release Jul 31 2024, 08:30 EDT (E)
Average Growth Rate 20.95%
Value from Last Quarter 659.00M
Change from Last Quarter -34.60%
Value from 1 Year Ago 409.00M
Change from 1 Year Ago 5.38%
Frequency Quarterly
Unit USD
Adjustment N/A

Related Securities

Symbol Name Change %
BDX Becton Dickinson & Co 1.47%